Apollo Endosurgery ROA 2006-2019 | APEN

Current and historical return on assets (ROA) values for Apollo Endosurgery (APEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Apollo Endosurgery ROA for the three months ending September 30, 2019 was -46.15%.
Apollo Endosurgery ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $-0.04B $0.08B -49.52%
2019-06-30 $-0.04B $0.08B -48.34%
2019-03-31 $-0.04B $0.08B -44.81%
2018-12-31 $-0.05B $0.07B -47.79%
2018-09-30 $-0.04B $0.10B -33.33%
2018-06-30 $-0.03B $0.11B -27.65%
2018-03-31 $-0.03B $0.10B -26.34%
2017-12-31 $-0.03B $0.11B -27.14%
2017-09-30 $-0.03B $0.11B -33.76%
2017-06-30 $-0.04B $0.09B -51.25%
2017-03-31 $-0.04B $0.09B -81.19%
2016-12-31 $-0.04B $0.10B -133.33%
2016-09-30 $-0.06B $0.00B -180.95%
2016-06-30 $-0.05B $0.01B -150.00%
2016-03-31 $-0.04B $0.01B -116.67%
2015-12-31 $-0.04B $0.11B -98.01%
2015-09-30 $-0.01B $0.01B -83.58%
2015-06-30 $-0.02B $0.02B -75.00%
2015-03-31 $-0.02B $0.02B -77.11%
2014-12-31 $-0.02B $0.02B -72.73%
2014-09-30 $-0.01B $0.03B -53.01%
2014-06-30 $-0.01B $0.02B -59.46%
2014-03-31 $-0.01B $0.02B -42.11%
2013-12-31 $-0.01B $0.02B -31.17%
2013-09-30 $-0.01B $0.02B -31.82%
2013-06-30 $-0.01B $0.02B -22.47%
2013-03-31 $-0.01B $0.02B -22.22%
2012-12-31 $-0.00B $0.03B -13.33%
2012-09-30 $-0.01B $0.02B -24.69%
2012-06-30 $-0.00B $0.02B -14.63%
2012-03-31 $-0.00B $0.02B -4.88%
2011-12-31 $-0.00B $0.02B -19.51%
2011-09-30 $-0.00B $0.02B -4.55%
2011-06-30 $-0.01B $0.02B -27.40%
2011-03-31 $-0.01B $0.02B -48.28%
2010-12-31 $-0.00B $0.02B -36.36%
2010-09-30 $-0.00B $0.01B -42.86%
2010-06-30 $0.01B $0.01B 90.32%
2010-03-31 $0.00B $0.01B 50.00%
2009-12-31 $0.00B $0.01B 51.61%
2009-09-30 $0.00B $0.01B 25.00%
2009-06-30 $-0.01B $0.01B -90.32%
2009-03-31 $-0.01B $0.01B -74.07%
2008-12-31 $-0.01B $0.01B -169.23%
2008-09-30 $-0.01B $0.01B -200.00%
2008-06-30 $-0.02B $0.00B -206.45%
2008-03-31 $-0.02B $0.01B -167.44%
2007-12-31 $-0.02B $0.01B -168.42%
2007-09-30 $-0.01B $0.01B -180.65%
2007-06-30 $-0.01B $0.02B -173.91%
2007-03-31 $-0.01B $0.00B -215.38%
2006-12-31 $-0.01B $0.00B -117.65%
2006-09-30 $-0.01B $0.00B -114.29%
2006-06-30 $-0.01B $0.01B -117.65%
2006-03-31 $-0.00B $0.01B -133.33%
2005-12-31 $-0.00B $0.01B -200.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.062B $0.061B
Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $128.061B 26.52
Intuitive Surgical (ISRG) United States $67.145B 52.77
Edwards Lifesciences (EW) United States $48.117B 43.69
Fresenius Medical Care AG KGaA (FMS) Germany $22.046B 14.92
IDEXX Laboratories (IDXX) United States $21.607B 52.26
Olympus (OCPNY) Japan $19.851B 149.08
DexCom (DXCM) United States $18.489B 165.57
Teleflex (TFX) United States $16.502B 33.50
Sysmex ADR (SSMXY) Japan $14.482B 38.98
Hologic (HOLX) United States $14.263B 21.80
SONOVA HOLDING (SONVY) Switzerland $14.163B 0.00
STERIS (STE) Ireland $13.028B 28.77
Varian Medical Systems (VAR) United States $12.895B 30.57
Masimo (MASI) United States $8.388B 50.09
ABIOMED (ABMD) United States $8.090B 44.02
Globus Medical (GMED) United States $5.745B 35.45
SARTORIUS AG (SARTF) Germany $5.614B 49.28
Penumbra (PEN) United States $5.563B 181.04
Integra LifeSciences Holdings (IART) United States $5.320B 22.86
Elekta AB (EKTAY) Sweden $4.737B 36.47
Wright Medical Group (WMGI) Netherlands $3.736B 226.46
LivaNova (LIVN) United Kingdom $3.712B 26.73
Tandem Diabetes Care (TNDM) United States $3.409B 0.00
Nevro (NVRO) United States $3.335B 0.00
Cantel Medical (CMD) United States $3.203B 31.35
Integer Holdings (ITGR) United States $2.607B 17.85
Nihon Kohden (NHNKY) Japan $2.374B 23.89
Glaukos (GKOS) United States $2.075B 0.00
Inogen (INGN) United States $1.577B 49.78
AVANOS MEDICAL, INC (AVNS) United States $1.544B 30.39
Veracyte (VCYT) United States $1.398B 0.00
Tactile Systems Technology (TCMD) United States $1.280B 146.26
Natus Medical (NTUS) United States $1.078B 25.91
Mesa Laboratories (MLAB) United States $1.074B 39.83
Silk Road Medical (SILK) United States $1.065B 0.00
OPKO Health (OPK) United States $1.018B 0.00
CryoLife (CRY) United States $0.977B 100.23
Luminex (LMNX) United States $0.975B 0.00
Accelerate Diagnostics (AXDX) United States $0.883B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.866B 28.78
Pacific Biosciences Of California (PACB) United States $0.831B 0.00
Intersect ENT (XENT) United States $0.677B 0.00
AxoGen (AXGN) United States $0.670B 0.00
OrthoPediatrics (KIDS) United States $0.644B 0.00
AngioDynamics (ANGO) United States $0.589B 21.16
Quotient (QTNT) Switzerland $0.582B 0.00
Si-Bone (SIBN) United States $0.477B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.453B 13.70
Sientra (SIEN) United States $0.436B 0.00
ViewRay (VRAY) United States $0.420B 0.00
Alphatec Holdings (ATEC) United States $0.403B 0.00
GenMark Diagnostics (GNMK) United States $0.311B 0.00
Stereotaxis (STXS) United States $0.311B 0.00
IRadimed (IRMD) United States $0.296B 41.55
Semler Scientific (SMLR) United States $0.294B 40.91
Accuray (ARAY) United States $0.253B 0.00
CRH Medical (CRHM) Canada $0.243B 67.80
SeaSpine Holdings (SPNE) United States $0.213B 0.00
Fluidigm (FLDM) United States $0.211B 0.00
RTI Surgical (RTIX) United States $0.181B 49.10
Restoration Robotics (VERO) Canada $0.145B 0.00
EDAP TMS S.A (EDAP) France $0.134B 35.46
Spectral Diagnostics (EDTXF) Canada $0.132B 0.00
ConforMIS (CFMS) United States $0.106B 0.00
Second Sight Medical Products (EYES) United States $0.096B 0.00
Neuronetics (STIM) United States $0.083B 0.00
Vermillion (VRML) United States $0.072B 0.00
Electromed (ELMD) United States $0.068B 24.24
Sensus Healthcare (SRTS) United States $0.061B 0.00
T2 Biosystems (TTOO) United States $0.054B 0.00
TransEnterix (TRXC) United States $0.044B 0.00
Ekso Bionics Holdings (EKSO) United States $0.044B 0.00
Bioanalytical Systems (BASI) United States $0.044B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.038B 0.00
Neovasc (NVCN) Canada $0.025B 0.00
Xtant Medical Holdings (XTNT) United States $0.023B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.021B 0.00
ReWalk Robotics (RWLK) Israel $0.018B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.17
DarioHealth (DRIO) Israel $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.015B 0.00
Helius Medical Technologies (HSDT) United States $0.014B 0.00
Avinger (AVGR) United States $0.013B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Ra Medical Systems (RMED) United States $0.012B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Dynatronics (DYNT) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Sunshine Heart Inc (CHFS) United States $0.004B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00